Résumé
As neurotechnologies transition from research labs to mainstream markets, they encounter a complex array of ethical considerations, regulatory frameworks, and market dynamics. The ethical and regulatory responses to the swift deployment of AI-powered neurotech are continually evolving. In this presentation, Oullier will build on his expertise in academia, policymaking, and business to champion proactive engagement with all stakeholders. This approach aims to ensure that the commercial expansion of neurotechnologies aligns with societal values and ethical principles, enhancing human capabilities while safeguarding fundamental rights. Additionally, he will address the risks posed by unregulated commercial practices as well as by poorly informed individuals involved in ethics and regulatory initiatives who are making non-evidence-based claims that could hinder both research and business progress in AI and neurotechnologies.
